Remove Food Remove Investment Remove Portfolio
article thumbnail

Goldman Sachs names five stocks with more upside following their latest earnings

CNBC: Investing

The Wall Street investment bank says stocks like Shake Shack have plenty of upside ahead. Other buy-rated names include: Tyson Foods, FMC, Match Group and Woodward. Tyson Foods The turnaround is underway at the poultry company, according to Goldman. The stock is down 25% this year through Friday.

article thumbnail

UBS gives 3 key AI stocks to own from here

CNBC: Investing

" UBS cautioned that the enterprise adoption pillar remains the one most at risk, given companies' slower adoption, a more uncertain investment return and the specific configuration necessary to adapt AI to individual needs. However, it believes that any risks resulting from this setup should still be manageable.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Bank of America says these five stocks have more room to run

CNBC: Investing

The health foods category remains strong, she wrote, especially as consumer choose new and different ways to diet. Bellring Brands The energy drink and nutrition products company is firing on all cylinders, according to analyst Yasmine Deswandhy.

article thumbnail

Investing Principles: Lessons Learned from 20 Years of Wins, Losses, and Strikeouts

Mergers and Inquisitions

Ive said before that nothing on this site is meant to be investment advice. That said, my annual investment/market updates always get a lot of traffic, so I thought it might be interesting to follow up on this years update with more of an advice article. If youre reading this right now, youre probably much younger than me.

article thumbnail

PCE Welcomes Bradley Scharfenberg as Vice President, M&A

PCE

Brad joins us with over a decade of investment banking experience, having advised on more than 30 middle-market M&A transactions across healthcare, consumer, and industrial sectors.

M&A
article thumbnail

Cooley’s 2024 Life Sciences M&A Year in Review: M&A Slims Down in 2024, but Will Appetites Grow in 2025?

Cooley M&A

Portfolio optimization through divestitures of noncore assets In addition to pharmas smaller appetite in 2024, pharma companies continued to slim down by shedding nonessential assets to sharpen their strategic focus on core products.

M&A
article thumbnail

Options traders are expecting a huge move on earnings from DoorDash. How to trade it

CNBC: Investing

First-quarter revenue missed estimates, despite beating earnings per share, as food delivery growth slowed to 13% year-over-year. THIS CONTENT IS PROVIDED FOR INFORMATIONAL PURPOSES ONLY AND DOES NOT CONSITUTE FINANCIAL, INVESTMENT, TAX OR LEGAL ADVICE OR A RECOMMENDATION TO BUY ANY SECURITY OR OTHER FINANCIAL ASSET.